16-84480010-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_020947.4(MEAK7):c.1274G>A(p.Ser425Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000249 in 1,603,502 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000021 ( 0 hom. )
Consequence
MEAK7
NM_020947.4 missense
NM_020947.4 missense
Scores
2
6
11
Clinical Significance
Conservation
PhyloP100: 3.40
Genes affected
MEAK7 (HGNC:29325): (MTOR associated protein, eak-7 homolog) Involved in several processes, including TOR signaling; positive regulation of protein localization to lysosome; and response to insulin. Located in cytosol; lysosomal membrane; and nuclear lumen. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.24263877).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MEAK7 | NM_020947.4 | c.1274G>A | p.Ser425Asn | missense_variant | 8/8 | ENST00000343629.11 | NP_065998.3 | |
MEAK7 | XM_005256075.3 | c.1274G>A | p.Ser425Asn | missense_variant | 9/9 | XP_005256132.1 | ||
MEAK7 | XM_017023511.2 | c.1274G>A | p.Ser425Asn | missense_variant | 8/8 | XP_016879000.1 | ||
MEAK7 | XM_047434410.1 | c.1274G>A | p.Ser425Asn | missense_variant | 8/8 | XP_047290366.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MEAK7 | ENST00000343629.11 | c.1274G>A | p.Ser425Asn | missense_variant | 8/8 | 1 | NM_020947.4 | ENSP00000343635 | P1 | |
MEAK7 | ENST00000566995.5 | c.*688G>A | 3_prime_UTR_variant, NMD_transcript_variant | 9/9 | 5 | ENSP00000454265 | ||||
MEAK7 | ENST00000570036.5 | c.*1329G>A | 3_prime_UTR_variant, NMD_transcript_variant | 9/9 | 2 | ENSP00000455332 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152252Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
1
AN:
152252
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000405 AC: 1AN: 246610Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 133388
GnomAD3 exomes
AF:
AC:
1
AN:
246610
Hom.:
AF XY:
AC XY:
0
AN XY:
133388
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000207 AC: 3AN: 1451250Hom.: 0 Cov.: 31 AF XY: 0.00000277 AC XY: 2AN XY: 721142
GnomAD4 exome
AF:
AC:
3
AN:
1451250
Hom.:
Cov.:
31
AF XY:
AC XY:
2
AN XY:
721142
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152252Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74388
GnomAD4 genome
AF:
AC:
1
AN:
152252
Hom.:
Cov.:
32
AF XY:
AC XY:
0
AN XY:
74388
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 19, 2024 | The c.1274G>A (p.S425N) alteration is located in exon 8 (coding exon 7) of the TLDC1 gene. This alteration results from a G to A substitution at nucleotide position 1274, causing the serine (S) at amino acid position 425 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
T
M_CAP
Benign
D
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M
MutationTaster
Benign
D;D
PrimateAI
Benign
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Uncertain
D
Sift4G
Pathogenic
D
Polyphen
P
Vest4
MutPred
Loss of phosphorylation at S425 (P = 0.0387);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at